Quick Takeaways
- Martin A. Lehr filed SCHEDULE 13G/A for Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX).
- Disclosed ownership: 2.1%.
- Date of event: 31 Dec 2024.
Martin A. Lehr - 31 Dec 2024 SCHEDULE 13G/A Report for Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX)
- Filing Manager
- Martin A. Lehr
- Reporting Manager
- Martin Lehr
- Symbol
- CNTX
- Shares outstanding
- 75,987,714 shares
- Disclosed Ownership
- 1,595,742 shares
- Ownership
- 2.1%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 17:20:20 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Martin A. Lehr disclosed 2.1% ownership in Context Therapeutics Inc. Common Stock, par value $0.001 per share (CNTX) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 17:20.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Martin Lehr | 2.1% | 1,595,742 | 775,552 | 820,190 | /s/ Martin Lehr | Martin Lehr | |
| Martin Lehr 2000 Trust | 1.1% | 820,190 | 0 | 820,190 | /s/ Ellyn Lehr | Ellyn Lehr/Trustee | |
| Ellyn Lehr | 1.1% | 820,190 | 0 | 820,190 | /s/ Ellyn Lehr | Ellyn Lehr |